These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18762055)
1. Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400). Stephenson AJ Urology; 2008 Sep; 72(3):719-20. PubMed ID: 18762055 [No Abstract] [Full Text] [Related]
2. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score. Zhao KH; Hernandez DJ; Han M; Humphreys EB; Mangold LA; Partin AW Urology; 2008 Aug; 72(2):396-400. PubMed ID: 18372031 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer. D'Amico AV; Chen MH J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151 [No Abstract] [Full Text] [Related]
5. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials. Nanda A; Chen MH; Renshaw AA; D'Amico AV Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185 [TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
8. Limitations and use of PSA velocity in the diagnosis and characterization of prostate cancer. Smith AD; Phillips JL Nat Clin Pract Urol; 2007 Nov; 4(11):576-7. PubMed ID: 17895878 [No Abstract] [Full Text] [Related]
9. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy. Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer with low PSA levels. Datta MW; Berman JJ; Dhir R N Engl J Med; 2004 Oct; 351(17):1802-3. PubMed ID: 15499672 [No Abstract] [Full Text] [Related]
11. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer. Mizuno R; Nakashima J; Mukai M; Okita H; Kosugi M; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M BJU Int; 2009 Nov; 104(9):1215-8. PubMed ID: 19389009 [TBL] [Abstract][Full Text] [Related]
12. [PSA kinetics after total prostatectomy]. Riedinger JM; Eche N; Fulla Y; Thuillier F Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884 [TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167 [TBL] [Abstract][Full Text] [Related]
15. Re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49:820-26. Beckley I; Khan MA Eur Urol; 2007 Oct; 52(4):1270; author reply 1271. PubMed ID: 17611016 [No Abstract] [Full Text] [Related]
16. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer. Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188 [TBL] [Abstract][Full Text] [Related]
17. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. Moreira DM; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614 [TBL] [Abstract][Full Text] [Related]
18. Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy. Xu DD; Sun SD; Wang F; Sun L; Stackhouse D; Polascik T; Albala DM; Moul JW; Caire A; Robertson CN Urology; 2009 Sep; 74(3):654-8. PubMed ID: 19628263 [TBL] [Abstract][Full Text] [Related]
19. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350). Oton CA Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937 [No Abstract] [Full Text] [Related]
20. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy. Bastian PJ Eur Urol; 2009 Feb; 55(2):420. PubMed ID: 19027222 [No Abstract] [Full Text] [Related] [Next] [New Search]